Biogen (BIIB) Non Operating Income (2009 - 2022)

Biogen (BIIB) has reported Non Operating Income for 14 consecutive years, with -$263.3 million the latest figure, recorded in Q1 2022.

• In Q1 2022, Non Operating Income rose 48.06% year-over-year to -$263.3 million; the TTM figure through Mar 2022 stood at -$851.9 million (down 867.48% YoY), while the FY2025 annual figure was -$305.6 million, up 11.06% from the prior year.
• Non Operating Income came in at -$263.3 million for Q1 2022 at Biogen, down from -$182.1 million in the prior quarter.
• The five-year high for Non Operating Income was $683.5 million in Q4 2020, with the low at -$506.9 million in Q1 2021.
• Average Non Operating Income over 5 years is -$45.1 million, with a median of -$41.0 million recorded in 2018.
• Across the five-year window, Non Operating Income plunged 472.17% in 2019 and soared 1486.41% in 2020, its largest moves.
• Year by year, Non Operating Income stood at -$28.6 million in 2018, then tumbled by 72.38% to -$49.3 million in 2019, then jumped by 1486.41% to $683.5 million in 2020, then tumbled by 126.64% to -$182.1 million in 2021, then plunged by 44.59% to -$263.3 million in 2022.
• According to Business Quant data, Non Operating Income over the past three periods registered -$263.3 million, -$182.1 million, and -$502.9 million for Q1 2022, Q4 2021, and Q3 2021 respectively.